Non-invasive assessment of glymphatic dysfunction in middle cerebral artery stenosis based on DTI-ALPS and ro-ALPS - Scorecard - MDSpire

Non-invasive assessment of glymphatic dysfunction in middle cerebral artery stenosis based on DTI-ALPS and ro-ALPS

  • By

  • Yidi Zhu

  • Luoyu Wang

  • Liqing Zhang

  • Xue Tang

  • Maoling Liu

  • Qingqing Wen

  • Darong Zhu

  • Han Zhang

  • Xiufang Xu

  • Zhongxiang Ding

  • June 17, 2026

  • 0 min

Share

Clinical Scorecard: Evaluation of Glymphatic Function in Middle Cerebral Artery Stenosis Through Non-Invasive DTI-ALPS and ro-ALPS Techniques

At a Glance

CategoryDetail
Condition
Key MechanismsImpaired cerebral perfusion and vascular pulsatility affecting cerebrospinal fluid dynamics.
Target Population
Care Setting

Key Highlights

  • Both DTI-ALPS and ro-ALPS indices were significantly lower in MCA-S patients compared to healthy controls (p < 0.001).
  • DTI-ALPS index negatively correlated with choroid plexus volume (r = -0.541, pFDR = 0.012).
  • ro-ALPS index also showed a negative correlation with choroid plexus volume (r = -0.568, pFDR < 0.001).

Guideline-Based Recommendations

Diagnosis

  • Confirm unilateral MCA-S through CTA, MRA, or DSA.

Management

    Monitoring & Follow-up

    • Utilize DTI-ALPS and ro-ALPS indices to assess perivascular clearance.

    Risks

    • Consider risks associated with atherosclerotic stenosis, including acute cardiovascular or cerebrovascular events.

    Patient & Prescribing Data

    Patients with unilateral MCA-S aged 18-80 years.

    Clinical Best Practices

      Related Resources & Content

      Original Source(s)

      Related Content